skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > oligosaccharide derivative > tetrasaccharide derivative > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > ureas > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > organosulfur heterocyclic compound > thiabicycloalkane > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
organic heterocyclic compound > organosulfur heterocyclic compound > thiabicycloalkane > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > thiabicycloalkane > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > organooxygen compound > carbonyl compound > carboxylic acid > monocarboxylic acid > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > organooxygen compound > carbon oxoacid > carboxylic acid > monocarboxylic acid > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > hydroxides > oxoacid > carbon oxoacid > carboxylic acid > monocarboxylic acid > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide
... > chemical entity > molecular entity > main group molecular entity > s-block molecular entity > hydrogen molecular entity > hydroxides > oxoacid > carbon oxoacid > carboxylic acid > monocarboxylic acid > biotins > n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide

اصطلاح مرجح

n-(3-/{[alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-(1->4)-alpha-d-galnac-yl]oxy/}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxadodecan-1-amide  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C60H104N8O30S

اینچی

  • InChI=1S/C60H104N8O30S/c1-31(73)63-44-49(80)48(79)36(26-69)92-57(44)96-54-38(28-71)94-59(46(51(54)82)65-33(3)75)98-55-39(29-72)95-58(47(52(55)83)66-34(4)76)97-53-37(27-70)93-56(45(50(53)81)64-32(2)74)91-13-7-11-61-42(78)10-14-85-16-18-87-20-22-89-24-25-90-23-21-88-19-17-86-15-12-62-41(77)9-6-5-8-40-43-35(30-99-40)67-60(84)68-43/h35-40,43-59,69-72,79-83H,5-30H2,1-4H3,(H,61,78)(H,62,77)(H,63,73)(H,64,74)(H,65,75)(H,66,76)(H2,67,68,84)/t35-,36+,37+,38+,39+,40-,43-,44+,45+,46+,47+,48-,49+,50+,51+,52+,53-,54-,55-,56-,57+,58+,59+/m0/s1

اینچی‌کی

  • WVVSTWNFWPTYDH-OERLUKOSSA-N

جرم

  • 1449.580

جرم تک‌ایزوتوپی

  • 1448.65791

اسمایلٓ

  • [C@H]1([C@@H]([C@H]([C@H]([C@H](O1)CO)O[C@@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(C)=O)O)NC(C)=O)O)NC(C)=O)O[C@@H]4[C@@H]([C@H]([C@H](O[C@@H]4CO)OCCCNC(CCOCCOCCOCCOCCOCCOCCNC(CCCC[C@H]5[C@]6(NC(N[C@]6(CS5)[H])=O)[H])=O)=O)NC(C)=O)O

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • N-(3-{[2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl]oxy}propyl)-23-oxo-27-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-4,7,10,13,16,19-hexaoxa-22-azaheptacosan-1-amide

مترادف مرتبط

  • 3-(21-biotinamino-4,7,10,13,16,19-hexaoxagenicaminoamino)-propyl 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-alpha-D-galactopyranoside
  • (3aS,4S,6aR)-N-[25-[[O-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]oxy]-21-oxo-3,6,9,12,15,18-hexaoxa-22-azapentacos-1-yl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide
  • N-(3-{[N-acetyl-alpha-D-galactosaminyl-(1->4)-N-acetyl-alpha-D-galactosaminyl-(1->4)-N-acetyl-alpha-D-galactosaminyl-(1->4)-N-acetyl-alpha-D-galactosaminyl]oxy}propyl)-21-(biotinylamino)-4,7,10,13,16,19-hexaoxaheptacosan-1-amide

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:146273

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD